Trial Profile
A double-blinded, randomized, crossover clinical study to assess the efficacy of Qutenza (capsaicin 8% patches) for the reduction of site pain caused by continuous subcutaneous infusion of Remodulin (treprostinil sodium), in Pulmonary Arterial Hypertension Patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2012
Price :
$35
*
At a glance
- Drugs Capsaicin (Primary)
- Indications Procedural pain
- Focus Adverse reactions; Therapeutic Use
- 07 Oct 2011 New trial record